BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31365378)

  • 21. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Prasse A; Kreuter M; Johow J; Rabe KF; Bonella F; Bonnet R; Grohe C; Held M; Wilkens H; Hammerl P; Koschel D; Blaas S; Wirtz H; Ficker JH; Neumeister W; Schönfeld N; Claussen M; Kneidinger N; Frankenberger M; Hummler S; Kahn N; Tello S; Freise J; Welte T; Neuser P; Günther A;
    Lancet Respir Med; 2021 May; 9(5):476-486. PubMed ID: 33798455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME
    AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of nailfold capillaroscopy in interstitial lung diseases - can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases?
    Çakmakçı Karadoğan D; Balkarlı A; Önal Ö; Altınışık G; Çobankara V
    Tuberk Toraks; 2015; 63(1):22-30. PubMed ID: 25849052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment.
    Pugashetti JV; Lee JS
    Semin Respir Crit Care Med; 2024 Jun; 45(3):329-341. PubMed ID: 38484788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
    Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of MUC5B gene on antisynthetase syndrome.
    López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
    Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances with pharmacotherapy for the treatment of interstitial lung disease.
    Comes A; Sgalla G; Perrotta A; Richeldi L
    Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis.
    Lee JS; La J; Aziz S; Dobrinskikh E; Brownell R; Jones KD; Achtar-Zadeh N; Green G; Elicker BM; Golden JA; Matthay MA; Kukreja J; Schwartz DA; Wolters PJ
    Histopathology; 2021 Jul; 79(1):67-76. PubMed ID: 33432658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The updated S2k guideline for the diagnosis of idiopathic pulmonary fibrosis : Essential aspects for pathology].
    Fink L; Jonigk D
    Pathologe; 2021 Feb; 42(1):40-47. PubMed ID: 33416935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
    Yoo H; Hino T; Han J; Franks TJ; Im Y; Hatabu H; Chung MP; Lee KS
    Eur J Radiol Open; 2021; 8():100311. PubMed ID: 33364263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of Chronic Hypersensitivity Pneumonitis What Is It? What Are the Diagnostic Criteria? Why Do We Care?
    Churg A; Bilawich A; Wright JL
    Arch Pathol Lab Med; 2018 Jan; 142(1):109-119. PubMed ID: 28537805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria.
    Yamakawa H; Sato S; Tsumiyama E; Nishizawa T; Kawabe R; Oba T; Kamikawa T; Horikoshi M; Akasaka K; Amano M; Kuwano K; Matsushima H
    J Thorac Dis; 2019 Dec; 11(12):5247-5257. PubMed ID: 32030242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms and management of cough in interstitial lung disease.
    Rasheed AZ; Metersky ML; Ghazal F
    Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution CT features distinguishing usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis from those with idiopathic pulmonary fibrosis.
    Tateishi T; Johkoh T; Sakai F; Miyazaki Y; Ogura T; Ichikado K; Suda T; Taguchi Y; Inoue Y; Takemura T; Colby TV; Sumikawa H; Fujimoto K; Arakawa H; Raoof S; Inase N
    Jpn J Radiol; 2020 Jun; 38(6):524-532. PubMed ID: 32103467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD).
    Yu M; Guo Y; Zhang P; Xue J; Yang J; Cai Q; You X; Ma J; Yang D; Jia Y; Wang Y; Li F; Chi S; Cao M; Chen J; Liu X
    Immunobiology; 2019 Jul; 224(4):551-559. PubMed ID: 31072629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes.
    Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
    BMC Pulm Med; 2016 Jul; 16(1):107. PubMed ID: 27461264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere length across different UIP fibrotic-Interstitial Lung Diseases: a prospective Greek case-control study.
    Tomos I; Karakatsani A; Manali ED; Kottaridi C; Spathis A; Argentos S; Papiris SA
    Pulmonology; 2022; 28(4):254-261. PubMed ID: 33358512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.